|Lansen Pharmaceutical Holdings Limited -- Hong Kong Stock|| |
HKD 1.5 0.02 1.32%
VP of Marketing and Bus. Devel.
Mr. Chen Xiao Yun is the Vice President of Marketing and Business Development of the Lansen Pharmaceutical Holdings Limited. Mr. Chen joined our Group in April 2013 and has over 23 years of experience in the pharmaceutical industry. Prior to joining our Group, Mr. Chen was the marketing director of Shanghai CP Guojian Pharmaceutical Co., Ltd
Age: 44 VP Since 2013
86 574 8309 9777 http://www.lansen.com.cn
Chen obtained a bachelor of engineering degree majoring in pharmaceutical chemistry from China Pharmaceutical University in 1992 and a master?s degree in business administration from Fudan University in 1999.
The company has return on total asset (ROA)
of 2.47 %
which means that it generated profit of $2.47 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 20.06 %
meaning that it generated $20.06 on every $100 dollars invested by stockholders.
The company has accumulated 95.62 M in total debt with debt to equity ratio (D/E) of 90.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Lansen Pharmaceutical Holdings Limited has Current Ratio of 1.06 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.
Lansen Pharmaceutical Holdings Limited, an investment holding company, develops, produces, and sells specialty prescription western pharmaceuticals for the treatment of rheumatic diseases in the People?s Republic of China and internationally. Lansen Pharmaceutical Holdings Limited (0503) is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Ningbo, and employs 820 people.